These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30100155)

  • 21. Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density.
    Destounis S; Johnston L; Highnam R; Arieno A; Morgan R; Chan A
    AJR Am J Roentgenol; 2017 Jan; 208(1):222-227. PubMed ID: 27824483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the feasibility of stratified breast cancer screening using a masking risk predictor.
    Alonzo-Proulx O; Mainprize JG; Harvey JA; Yaffe MJ
    Breast Cancer Res; 2019 Aug; 21(1):91. PubMed ID: 31399056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography.
    Keller BM; Chen J; Daye D; Conant EF; Kontos D
    Breast Cancer Res; 2015 Aug; 17():117. PubMed ID: 26303303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breasts: Reader Study of Mammography-Negative and Mammography-Positive Cancers.
    Giger ML; Inciardi MF; Edwards A; Papaioannou J; Drukker K; Jiang Y; Brem R; Brown JB
    AJR Am J Roentgenol; 2016 Jun; 206(6):1341-50. PubMed ID: 27043979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of global and local region-based bilateral mammographic feature asymmetry to predict short-term breast cancer risk.
    Li Y; Fan M; Cheng H; Zhang P; Zheng B; Li L
    Phys Med Biol; 2018 Jan; 63(2):025004. PubMed ID: 29226849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients for Supplemental Breast Cancer Screening.
    Liu Y; Sorkhei M; Dembrower K; Azizpour H; Strand F; Smith K
    Radiology; 2024 Apr; 311(1):e232535. PubMed ID: 38591971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographic texture resemblance generalizes as an independent risk factor for breast cancer.
    Nielsen M; Vachon CM; Scott CG; Chernoff K; Karemore G; Karssemeijer N; Lillholm M; Karsdal MA
    Breast Cancer Res; 2014 Apr; 16(2):R37. PubMed ID: 24713478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
    Timmermans L; Bleyen L; Bacher K; Van Herck K; Lemmens K; Van Ongeval C; Van Steen A; Martens P; De Brabander I; Goossens M; Thierens H
    Eur Radiol; 2017 Sep; 27(9):3810-3819. PubMed ID: 28289944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction.
    Dembrower K; Liu Y; Azizpour H; Eklund M; Smith K; Lindholm P; Strand F
    Radiology; 2020 Feb; 294(2):265-272. PubMed ID: 31845842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk.
    Giorgi Rossi P; Djuric O; Hélin V; Astley S; Mantellini P; Nitrosi A; Harkness EF; Gauthier E; Puliti D; Balleyguier C; Baron C; Gilbert FJ; Grivegnée A; Pattacini P; Michiels S; Delaloge S
    Sci Rep; 2021 Oct; 11(1):19884. PubMed ID: 34615978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic Density Distribution in Ras Al Khaimah (RAK): Relationships with Demographic and Reproductive Factors.
    Albeshan SM; Hossain SZ; Mackey MG; Demchig D; Peat JK; Brennan PC
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1607-1616. PubMed ID: 29936786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of mammographic breast density and its correlation with BI-RADS in elder women using machine learning approach.
    Lee ZY; Goh YLE; Lai C
    J Med Imaging Radiat Sci; 2022 Mar; 53(1):28-34. PubMed ID: 34801440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy.
    Burnside ES; Liu J; Wu Y; Onitilo AA; McCarty CA; Page CD; Peissig PL; Trentham-Dietz A; Kitchner T; Fan J; Yuan M
    Acad Radiol; 2016 Jan; 23(1):62-9. PubMed ID: 26514439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.
    Nguyen TL; Aung YK; Evans CF; Dite GS; Stone J; MacInnis RJ; Dowty JG; Bickerstaffe A; Aujard K; Rommens JM; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Apicella C; Hopper JL
    Int J Epidemiol; 2017 Apr; 46(2):652-661. PubMed ID: 28338721
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.